Lv1
40 积分 2023-11-07 加入
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes
4个月前
已完结
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
8个月前
已完结
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
8个月前
已关闭
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
8个月前
已完结
Treatment for relapsed acute promyelocytic leukemia
9个月前
已完结
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
9个月前
已完结
Biomarkers to Differentiate Acute Chest Syndrome From Vaso‐Occlusive Crisis in Children With Sickle Cell Disease
11个月前
已完结
Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination
11个月前
已完结
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
1年前
已完结
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
1年前
已关闭
皖公网安备34019202002308
